The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zabolotskikh I.B.

Kuban State Medical University

Lebedinskii K.M.

North-Western State Medical University n.a. Mechnikov, Federal Research;
Clinical Center of Intensive Care Medicine and Rehabilitology

Potievskaya V.I.

Herzen Moscow Research Oncological Institute — Branch of the National Medical Research Center of Radiology

Bautin A.E.

North-West Federal Medical Research Center named after V.A. Almazov

Eremenko A.A.

Petrovsky National Research Center of Surgery;
Sechenov First Moscow State Medical University

Alekseeva Yu.M.

Federal Scientific Clinical Center of the Federal Medical and Biological Agency

Doroginin S.V.

Regional State Budgetary healthcare institution Clinical Hospital No. 1

Perioperative management of patients with ventricular tachycardia

Authors:

Zabolotskikh I.B., Lebedinskii K.M., Potievskaya V.I., Bautin A.E., Eremenko A.A., Alekseeva Yu.M., Doroginin S.V.

More about the authors

Read: 27810 times


To cite this article:

Zabolotskikh IB, Lebedinskii KM, Potievskaya VI, Bautin AE, Eremenko AA, Alekseeva YuM, Doroginin SV. Perioperative management of patients with ventricular tachycardia. Russian Journal of Anesthesiology and Reanimatology. 2020;(6):6‑22. (In Russ.)
https://doi.org/10.17116/anaesthesiology20200616

Recommended articles:

References:

  1. Miller’s Anesthesia. 7th Edition. Russian translation. 2015;3329. (In Russ.).
  2. Clinical Arrhythmology. Pod red. prof. Ardasheva A.V. M.: ID «Medpraktika-M»; 2009. (In Russ.).
  3. Gel’fand BR, Zabolotskih IB i dr. National guidelines for intensive care. M.: GEHOTAR-Media; 2017. (In Russ.).
  4. Boldueva SA, Spabrov AV, Lebedev DS i dr. Prognosis and prophylaxis of sudden cardiac death. Kardiovaskulyarnaya terapiya i profilaktika. 2008;7(3):56-62. (In Russ.).
  5. Green DH, Townsend P, Bagshaw O, Stokes MA. Nodal rhythm and bradycardia during inhalation induction with sevoflurane in infants: A comparison of incremental and high-concentration techniques. Br J Anaesth. 2000;85:368-370. 
  6. Owczuk R, Wujtewicz MA, Sawicka W, et al. The Influence of desflurane on QTc interval. Anesth Analg. 2005;101:419-422. 
  7. Reiz S, Nath S. Cardiotoxicity of local anesthetic agents. Br J Anaesth. 1986;58:736-746. 
  8. Burov N.E, Potapov VN. Xenon in medicine: hystorical essays about use of medical xenon. M.: Pul’s; 2012. (In Russ.).
  9. Hogan Q. Toxicity of local anesthetics. Reg Anesth. 1996;21(6):43-50. 
  10. Clinical anesthesiology. Book1. Edition 2nd, revised. Translation from English. M.—SPb.: Izdatel’stvo BINOM-Nevskij Dialekt; 2001. (In Russ).
  11. Rosenblatt MA, Abel M, Fischer GW, et al. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006;105:217-218. 
  12. Weinberg G. Lipid infusion resuscitation for local anesthetic toxicity: Proof of clinical efficacy. Anesthesiology. 2006;105:7-8. 
  13. Edwards R, Winnie AP, Ramamurthy S. Acute hypocapneic hypokalemia: An iatrogenic anesthetic complication. Anesth Analg. 1977;56:786-792. 
  14. Samuel MA. The brain-heart connection. Circulation. 2007;116:77-84. 
  15. Kristensen S, Knuuti J, Saraste A, Anker S, Botker H, De Hert S, Ford I, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. European Heart Journal. 2014;35:2383-2431.
  16. Bojcov SA, Nikulina NN, YAkushin SS i dr. Sudden cardiac death in patients with ischemic heart disease: prevalence, detectability and problems of statistical accounting. Rossijskij kardiologicheskij zhurnal. 2011;2:59-64. (In Russ.).
  17. National guidelines for risk detection and prophylaxis of sudden cardiac death. M.: ID «MEDPRAKTIKA-M»; 2013. (In Russ.).
  18. Mazur NA. Sudden death. V kn.: Bolezni serdca i sosudov. Pod red. Chazova E.I. M.: Medicina; 1992. (In Russ.).
  19. Mazur NA. Sudden death in patients with ischemic heart disease. M.: Medicina; 1985. (In Russ.).
  20. Goldstein S, Bayes-de-Luna A, Gumdo-Soldevila J. Sudden cardiac death. Armonk: Futura; 1994.
  21. Gruberg L, et al. SCD-HeFT: Sudden Cardiac Death in Heart Failure Trial. Medscape Cardiology. 2004;16. 
  22. Al-Khatib SM, Sanders GD, Cicik A, et al. Preventing tomorrow’s sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am H Jour. 2008;156:613-622. 
  23. Aziz EF, Javed F, Pratap B, Herzog E. Strategies for the prevention and treatment of sudden cardiac death. Open Access Emerg Med. 2010;2:99-114. 
  24. Christine M. Albert. Prediction of Sudden Cardiac Death in Patients With Coronary Heart Disease: The Challenge Ahead. Circ Cardiovasc Imaging. 2008;1:175-177. 
  25. Mark Estes NA, et al. The Challenge of Predicting and Preventing Sudden Cardiac Death Immediately After Myocardial Infarction. Circulation. 2009;120:185-187. 
  26. Bokeriya LA, Bokeriya OL, Kirtbaya LN. Heart failure and sudden cardiac death. Annaly aritmologii. 2009;4:7-20. (In Russ.).
  27. Uretsky BF, Thygesen K, Daubert JC, et al. Predictors of Mortality From Pump Failure and Sudden Cardiac Death in Patients With Systolic Heart Failure and Left Ventricular Dyssynchrony: Results of the CARE-HF Trial. Journal of Cardiac Failure. 2008;14(8):670-675. 
  28. Meune C, Van Berlo JH. Anselme F, et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med. 2006;354:209-210. 
  29. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. 
  30. Spirito P, Autore C, Rapezzi C, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119:1703-1710.
  31. Heintz KM, Hollenberg SM. Perioperative cardiac issues: Postoperative arrhythmias. Surg Clin North Am. 2005;85:1103-1114.
  32. Mahla E, Rotman B, Rehak P, et al. Perioperative ventricular dysrhythmias in patients with structural heart disease undergoing noncardiac surgery. Anesth Analg. 1998;86:16-21. 
  33. ACC/AHA/ESC 2006. Guidelines for Management of Patients With Ventricular Arrythmias and the Prevention of Sudden Cardiac Death. Europace. 2006;8:746-837. 
  34. Bigger JT, Bigger JT, Fleiss JL, Kjeiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250. 
  35. Wellens HJJ. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014;35:1642-1651.
  36. George S, Rodriguez I, Ipe D, et al. computerized extraction of electrocardiograms from continuus 12-lead Holter recordings reduces measurement variability in a thorough QT study. J Clin Pharmacol. 2012;52:1891-1900.
  37. Bauer A, Malik M, Schmidt G, et al. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol. 2008;52(17):1353-1365. https://doi.org/10.1016/j.jacc.2008.07.041
  38. Narain R, Dhutia H, Merghani A, Myers J, Malhotra A, Millar L, Sheikh N, Sharma S, Papadakis M. Preventing sudden cardiac death in the young: results from a population-based screening program in the UK. European Journal of Preventive Cardiology. 2014;21(suppl):1-6. 
  39. Belyalov FI. Practical Arrhythmology. Monograph. Irkutsk: RIO IGIUVa; 2009. (In Russ.).
  40. Delgado V, Bucciarelli-Ducci C, Bax JJ. Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance. Journal of Nuclear Cardiology. 2016;23(6):1399-1410.
  41. Kuznetsov VA, Yurkina YuA, Todosiychuk VV, Lykasova EA, Nohrina OYu, Krinochkin DV i dr. Predictors of high-grade ventricular arrhythmias in patients referred for the coronary angiography. Kardiologiya. 2014;8:44-48. (In Russ.).
  42. Zafari AM, Zarter SK, Hellen V, et al. A programen couraging early defibrillation results in improved inhospital resuscitation efficacy. J Am Coll Cardiol. 2004;44:846-852. 
  43. Hutchins D. Peri-operative Cardiac Arrhythmias. Part 1. ATOTW 279 —04/02/2013. Royal Devon & Exeter Hospital, UK. 
  44. Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American ESC/ESA Guidelines 2429 Downloaded from https://eurheartj.oxfordjournals.org/ by guest on November 26, 2015 Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2010;55:934-947.
  45. Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. ESC Clinical Practice Guidelines. Rossijskij kardiologicheskij zhurnal. 2016;7(135):5-86. (In Russ.).
  46. Maron BJ. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy. Circ J. 2010;74:2271-2282.
  47. Ungar A, Del Rosso A, Giada F, et al. Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study. Eur Heart J. 2010;32:2021-2026.
  48. Shlyahto EV, Novikova IV, Rudakov MM, Treshkur TV. Ventricular arrhythmias in patients with ischemic heart disease: modern concepts of etiopathogenesis, diagnosis and treatment. Vest. aritmologii. 2002;30:72-75. (In Russ.).
  49. European Resuscitation Council Guidelines for Resuscitation 2015. Section 2. Adult basic life support and automated external defibrillation. Resuscitation. 2015;95:81-99. 36b European Resuscitation Council Guidelines for Resuscitation 2015. Section 3. Adult advanced life support. Resuscitation. 2015;95:100-147. 
  50. Dargie HJ. Effect CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial. Lancet. 2001;357:1385-1390.
  51. Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van deWerf F, Solomon SD, Califf RM, Velazquez EJ. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Am J Cardiol. 2008;102:1427-1432.
  52. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-404. 
  53. Myasnikova VV, Karahalis NB, Musaeva TS, Zabolotskih IB. Perioperative management of patients with tachyarrhythmias in non-cardiac surgery. Vestnik intensivnoj terapii. 2017;1:37-55. (In Russ.).
  54. Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, et al. Relationship between intra-operative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507-515. 
  55. Marshall BE, Longnecher DE. General Anesthetics. In: Gilman A.G., Rail T.W., Nies A.S., Taylor P. The Pharmacological Basis of Therapeutics. 8th ed. New York, Permagon; 1990.
  56. Lazlo A, Polk S, Atlee JL, Kampine JP, Bosnjak ZJ. Anesthetics and automaticity in latent pacemaker fibers: I. Effects of halothane, enflurane, and isoflurane on automaticity and recovery of automaticity from overdrive suppression in Purkinje fibers derived from canine hearts. Anesthesiology. 1991;75:98-105. 
  57. Sharpe MD, Cuillerier DJ, Lee JK, et al. Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Anesthesiology. 1999;90(1):60-65. 
  58. Cozanitis DA, Lindgren L Rosenberg PH. Bradycardia in patients receiving atracurium or vecuronium in conditions of low vagal stimulation. Anaesthesia. 1989; 44:303-305. 
  59. Warpechowski P, Lima GG, Medeiros CM, et al. Randomized study of propofol effect on electrophysiological properties of the atrioventricular node in patients with nodal reentrant tachycardia. Pacing Clin Electrophysiol. 2006;29(12):1375-1382.
  60. Lorentz MN, Vianna BSB. Cardiac Dysrhythmias and Anesthesia. Rev Bras Anestesiol. 2011;61:6:798-813. 
  61. Healey JS, Merchant R, Simpson C, Tang T, Beardsall M, Tung S, et al. Canadian Cardiovascular Society/Canadian Anesthesiologists’ Society/Canadian Heart Rhythm Society joint position statement on the peri-operative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. Can J Cardiol. 2012;28:141-151. 
  62. Popping DM, Elia N, Van Aken HK, Marret E, Schug SA, Kranke P et al. Impact of Epidural Analgesia on Mortality and Morbidity After Surgery: Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann Surg. 2013.
  63. Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F Nicotra F et al. Myocardial infarction and individual nonsteroidal antiinflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2013.
  64. Guidelines for cardiac rhythm disturbances. Pod red. Chazova E.I., Golicyna S.P. M.: GEHOTAR-Media; 2010. (In Russ.).
  65. Revishvili ASh, Boytsov SA, Davtyan KV, Zenin SA, Kuznetsov VA, Kuptsov VV i dr. Clinical guidelines for electrophysiological studies, cateter ablation and use of implanted antiarrhythmic devices. GEHOTAR Media; 2017. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.